Carprieve 50 mg/ml Solution for Injection for Cattle

देश: आयरलैंड

भाषा: अंग्रेज़ी

स्रोत: HPRA (Health Products Regulatory Authority)

सक्रिय संघटक:

Carprofen

थमां उपलब्ध:

Norbrook Laboratories (Ireland) Limited

ए.टी.सी कोड:

QM01AE91

INN (इंटरनेशनल नाम):

Carprofen

डोज़:

50 milligram(s)/millilitre

फार्मास्यूटिकल फॉर्म:

Solution for injection

प्रिस्क्रिप्शन प्रकार:

POM: Prescription Only Medicine as defined in relevant national legislation

चिकित्सीय क्षेत्र:

carprofen

प्राधिकरण का दर्जा:

Authorised

प्राधिकरण की तारीख:

2007-05-04

उत्पाद विशेषताएं

Health Products Regulatory Authority
27 February 2019
CRN008VG6
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Carprieve 50 mg/ml Solution for Injection for Cattle
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCE:
Carprofen 50 mg
EXCIPIENTS:
Ethanol (anhydrous) 100 mg
Sodium Formaldehyde Sulphoxylate 2 mg
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Solution for Injection.
A clear colourless to pale yellow solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
The product is indicated as an adjunct to antimicrobial therapy to
reduce pyrexia in acute cases of infectious respiratory
disease in cattle.
4.3 CONTRAINDICATIONS
Do not use in animals suffering from cardiac, hepatic or renal
impairment.
Do not use in animals suffering from gastrointestinal ulceration or
bleeding.
Do not use where there is evidence of a blood dyscrasia.
Do not use in animals with known hypersensitivity to the product.
For use in pregnant animals refer to section 4.7.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Do not exceed the stated dose or the duration of treatment.
Do not administer other NSAIDs concurrently or within 24 hours of each
other. Some NSAIDs may be highly bound to plasma
proteins and compete with other highly bound drugs, which can lead to
toxic effects.
Use in any animal less than 6 weeks of age, or in aged animals, may
involve additional risk. If such use cannot be avoided
animals may require a reduced dosage and careful clinical management.
Health Products Regulatory Authority
27 February 2019
CRN008VG6
Page 2 of 5
Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as
there is a potential risk of increased renal toxicity.
Concurrent administration of potentially nephrotoxic drugs should be
avoided.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDIC